Related Experiment Video

Updated: Aug 5, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Autologous stem cell transplantation for pediatric rheumatic diseases

K S Barron1, C Wallace, Woolfrey CEA

  • 1Division of Intramural Research, National Institute Allergy and Infectious Diseases, and the Office of Rare Diseases, National Institutes of Health, Bethesda, Maryland 20892-1356, USA. Kbarron@nih.gov

The Journal of Rheumatology
|October 24, 2001
PubMed

Insights

Autologous stem cell transplantation shows promise for pediatric rheumatic diseases. This workshop focused on developing protocols, exploring transplantation specifics, and addressing regulatory and data repository needs for this innovative therapy.

Area of Science:

  • Pediatric Rheumatology
  • Hematology
  • Immunology

Background:

  • Autologous stem cell transplantation (ASCT) is an emerging therapy for severe pediatric rheumatic diseases.
  • A workshop convened by the National Institute of Allergy and Infectious Disease (NIAID) addressed the need for standardized protocols.
  • Focus areas included the scientific rationale and unique considerations for ASCT in pediatric rheumatic conditions.

Framework:

  • The workshop established a framework for developing robust ASCT protocols.
  • Key components discussed were transplantation techniques, patient selection, and potential complications.
  • Addressing the specific challenges of applying ASCT to pediatric rheumatic diseases was central.

Implementation:

  • Exploration of various transplantation options and logistical issues was undertaken.
  • Regulatory pathways and requirements for ASCT in pediatric populations were examined.
  • The establishment of a DNA repository for research was proposed to advance understanding.

Implications:

  • Standardized protocols are crucial for the safe and effective implementation of ASCT.
  • Further research is needed to optimize ASCT for pediatric rheumatic diseases.
  • Development of a DNA repository will facilitate genetic and translational research.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Concept Videos

Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...